Legend Biotech Corp. (LEGN)
15.99
-1.51
(-8.63%)
USD |
NASDAQ |
Nov 16, 16:00
16.10
+0.11
(+0.69%)
After-Hours: 20:00
Legend Biotech Total Liabilities (Quarterly) : 408.69M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 408.69M |
| June 30, 2026 | 521.32M |
| March 31, 2026 | 629.02M |
| December 31, 2025 | 723.60M |
| September 30, 2025 | 693.56M |
| June 30, 2025 | 647.50M |
| March 31, 2025 | 591.84M |
| December 31, 2024 | 623.45M |
| September 30, 2024 | 613.17M |
| June 30, 2024 | 632.61M |
| March 31, 2024 | 604.38M |
| December 31, 2023 | 589.93M |
| September 30, 2023 | 492.93M |
| June 30, 2023 | 516.59M |
| Date | Value |
|---|---|
| March 31, 2023 | 548.57M |
| December 31, 2022 | 578.99M |
| September 30, 2022 | |
| June 30, 2022 | 453.67M |
| March 31, 2022 | 301.14M |
| December 31, 2021 | 351.66M |
| September 30, 2021 | 585.98M |
| June 30, 2021 | 533.21M |
| March 31, 2021 | 406.85M |
| December 31, 2020 | 122.27M |
| September 30, 2020 | 371.71M |
| June 30, 2020 | 371.86M |
| March 31, 2020 | 531.27M |
| December 31, 2019 | 410.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 38.45B |
| Ionis Pharmaceuticals, Inc. | 2.519B |
| Cellectar Biosciences, Inc. | 7.328M |
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.681B |
| Shareholders Equity (Quarterly) | 1.273B |
| Debt to Equity Ratio | 0.1315 |
| Current Ratio | 3.953 |
| Net Debt Paydown Yield | 1.14% |